Quest diagnostics reports fourth quarter and full year 2024 financial results; provides guidance for full year 2025; increases quarterly dividend 6.7% to $0.80 per share

Fourth quarter revenues of $2.62 billion, up 14.5% from 2023 fourth quarter reported diluted earnings per share ("eps") of $1.95, up 14.7% from 2023; and adjusted diluted eps of $2.23, up 3.7% from 2023 full year revenues of $9.87 billion, up 6.7% from 2023 full year reported diluted eps of $7.69, up 2.7% from 2023; and adjusted diluted eps of $8.93, up 2.5% from 2023 full year 2025 reported diluted eps expected to be between $8.34 and $8.59; and adjusted diluted eps expected to be between $9.55 and $9.80 secaucus, n.j. , jan. 30, 2025 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), a leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended december 31, 2024.
DGX Ratings Summary
DGX Quant Ranking